Selank Australia: Anxiolytic Research Peptide Guide | Quantum Labs
Selank research guide for Australia — tuftsin-derived heptapeptide, vs Semax, intranasal delivery, legality framing, purity standards, and catalogue links.
What is Selank?
Selank is a synthetic heptapeptide developed in the same Russian peptide-research lineage as Semax. Its sequence is derived from tuftsin (Thr-Lys-Pro-Arg), a fragment of the immunoglobulin G heavy chain, extended with a Pro-Gly-Pro motif that improves metabolic stability. In the published literature, Selank is studied primarily as an anxiolytic and immunomodulatory research peptide — not as a classical stimulant or secretagogue.
Quantum Labs supplies Selank as lyophilised research material for Australian laboratory use, HPLC-verified to a ≥99% purity specification. It sits alongside Semax in the nootropic / CNS peptide cluster and is commonly discussed with intranasal delivery.
Why researchers study Selank
Russian and Eastern European literature clusters Selank research around anxiety-related behavioural models, learning and memory paradigms, and neuroimmune signalling. Unlike many Western “nootropic” discussions that emphasise acute focus, Selank papers often frame outcomes in terms of stress resilience and GABA-related or enkephalin-related pathway interest — always model-dependent.
Framing for Australian readers: Selank is not an approved Australian medicine for anxiety, cognition, or immune disease. Quantum Labs supplies it for research use only. Clinical questions belong with a registered medical practitioner.
Selank vs Semax
The two peptides share a research culture and delivery route more than they share a receptor map. Semax is an ACTH(4–10)-based analogue studied for nootropic and neuroprotective endpoints. Selank is tuftsin-derived and studied more often for anxiolytic and immune-modulatory themes. Combined protocols appear in informal stack discussions because the endpoints are complementary on paper — formal comparative trials are limited, so dual designs should be treated as exploratory research.
For the Semax-side deep dive, see our Semax Australia research guide. For delivery mechanics shared by both: nasal spray peptides Australia.
Intranasal research practicalities
Most Selank protocols use the intranasal route after reconstituting lyophilised powder into an aqueous vehicle. Nose-to-brain transport is the theoretical advantage for CNS-oriented models. Laboratory hygiene still applies: sterile technique, batch logging, cold storage of working solutions, and limited freeze–thaw cycles.
- Use reconstitution maths rather than estimating volumes
- Track post-reconstitution dating with the storage stability tool
- Stock bacteriostatic water when multi-use vials are part of the design
Australian supply and legality framing
As with other research peptides, legality and compliance hinge on intended use and claims. Compounded human therapeutics and research compounds are different channels under Australian frameworks. Quantum Labs ships Selank without therapeutic representation for laboratory work only. Broader context: are peptides legal in Australia and the research peptides Australia guide.
Purity standards that matter for CNS peptides
Behavioural and biomarker endpoints are sensitive to impurity noise. Our floor for Selank matches the catalogue standard: HPLC ≥99%, identity support, third-party testing, and COAs on request — detailed on the quality page.
Where Selank sits in the catalogue
Selank for Australian research supply. HPLC-verified ≥99% purity, third-party tested, Australian dispatch. View Selank · Semax guide · Quality & COAs.
